Related Experiment Video
Updated: Jul 10, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Proteome-based diagnostics and prognosis of bladder transitional cell carcinoma
Ting-Feng Wu1, Wan-Ling Ku, Yeou-Guang Tsay
1Southern Taiwan University, Department of Biotechnology, Tainan, Taiwan. wutingfe@mail.stut.edu.tw
Expert Review of Proteomics
|October 19, 2007
Summary
Proteomics aids in early bladder cancer detection and recurrence prediction. This review explores proteomic strategies for improved bladder transitional cell carcinoma diagnosis and treatment.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Over 90% of bladder tumors are transitional cell carcinomas.
- 70% are superficial papillary lesions (pTa, T1) with high recurrence rates.
- Tumor progression and muscle invasion are concerns for superficial bladder cancers.
Purpose of the Study:
- To review the application of proteomic technology in bladder cancer research.
- To explore proteomic strategies for early detection of bladder tumors.
- To identify proteomic approaches for predicting recurrence and guiding therapeutic interventions.
Main Methods:
- Review of existing literature on proteomic applications in bladder cancer.
- Analysis of proteomic studies focused on biomarker discovery.
- Synthesis of findings related to early diagnosis, recurrence prediction, and therapeutic targets.
Main Results:
- Proteomics offers potential for identifying biomarkers for early bladder cancer detection.
- Proteomic analysis can help predict tumor recurrence and progression.
- Novel therapeutic targets for bladder cancer intervention are being identified through proteomic research.
Conclusions:
- Proteomic technology is a valuable tool in advancing bladder cancer diagnostics.
- Further research using proteomics can lead to improved patient outcomes through personalized treatment strategies.
- Proteomics holds promise for developing new diagnostic and therapeutic approaches for bladder transitional cell carcinoma.
